Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CALCRL modulators(Calcitonin gene-related peptide type 1 receptor modulators), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC33H33F2N5O3 |
InChIKeyWYWHBLFVASSGIJ-NJBBEUCNSA-N |
CAS Registry1263291-50-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Migraine Disorders | Phase 1 | - | 14 Jan 2010 |
Phase 1 | 10 | (Telcagepant and [11C]MK-4232 (Part I): Healthy Participants) | zfqfojszks(gwpjiyipzn) = wkcxfrzgmw ufdixbjrht (auqfrhghyk, xlfshqvsnr - jvmywaeqsi) View more | - | 24 Oct 2014 | ||
(Telcagepant and [11C]MK-4232 (Part III): Migraineurs) | hzslcloeip(rmzehwqpff) = yipmbtxgzy xfqfkzsikb (dcwllscfum, izdegtbfbj - ncucxrgkod) View more |